Table 2. Incidence of falls outcomes at follow-up by OH categories (OH40 and sustained OH) and presence or absence of hypertension measured in both supine and seated positions.

	Recurrent falls	Injurious falls	Unexplained falls	Syncope
N	1498	1500	1500	1494
Total	307 (20.5)	305 (20.3)	184 (12.3)	149 (10.0)
OH40
OH40 -ve (79.1%)	224 (18.9)	216 (18.2)	128 (10.8)	110 (9.3)
OH40 +ve (20.9%)	83 (26.5)	89 (28.3)	56 (17.8)	39 (12.5)
Sustained OH
OHsus -ve (91.8%)	276 (20.1)	264 (19.2)	161 (11.7)	131 (9.6)
OHsus +ve (8.2%)	31 (25.2)	41 (33.3)	23 (18.7)	18 (14.6)
Using supine blood pressure (n = 1500)
Normotensive (n = 757)	158 (20.9)	151 (20.0)	92 (12.2)	74 (9.8)
Hypertensive (n = 743)	149 (20.1)	154 (20.7)	92 (12.4)	75 (10.1)
OH40
OH40 & HTN- (17.6%)	35 (26.3)	34 (25.6)	25 (18.8)	20 (15.2)
OH40 & HTN+ (24.4%)	48 (26.7)	55 (30.4)	31 (17.1)	19 (10.6)
Sustained OH
OHsus & HTN- (5.9%)	14 (31.1)	17 (37.8)	9 (20.0)	8 (17.8)
OHsus & HTN+ (10.5%)	17 (21.8)	24 (30.8)	14 (18.0)	10 (12.8)
Using seated blood pressure (n = 1491)
Normotensive (n = 764)	154 (20.2)	161 (21.1)	93 (12.2)	75 (9.9)
Hypertensive (n = 727)	152 (21.0)	144 (19.8)	90 (12.4)	73 (10.1)
OH40
OH40 & HTN- (19.0%)	32 (22.1)	33 (22.8)	20 (13.8)	19 (13.2)
OH40 & HTN+ (23.0%)	51 (30.7)	56 (33.5)	36 (21.6)	20 (12.1)
Sustained OH
OHsus & HTN- (7.3%)	12 (21.4)	16 (28.6)	7 (12.5)	8 (14.3)
OHsus & HTN+ (9.2%)	19 (28.4)	25 (37.3)	16 (23.9)	10 (14.9)

ACE, angiotensin-converting enzyme; HTN-, not classified as having hypertension; HTN+, classified as having hypertension; OH40, orthostatic hypotension at 40 seconds. Note that recurrent falls data were available for 1498 participants, injurious and unexplained falls data for 1500 participants and syncope data for 1494 participants.